NORTRIPTYLINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for nortriptyline hydrochloride and what is the scope of patent protection?
Nortriptyline hydrochloride
is the generic ingredient in four branded drugs marketed by Lilly, Ani Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Rising, Taro, Teva, Zydus Lifesciences, Specgx Llc, Ranbaxy, Pharm Assoc, and Rubicon, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for nortriptyline hydrochloride. Twenty-eight suppliers are listed for this compound.
Summary for NORTRIPTYLINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 12 |
NDAs: | 15 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 28 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 50 |
Patent Applications: | 2,160 |
What excipients (inactive ingredients) are in NORTRIPTYLINE HYDROCHLORIDE? | NORTRIPTYLINE HYDROCHLORIDE excipients list |
DailyMed Link: | NORTRIPTYLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for NORTRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chang Gung Memorial Hospital | Phase 2 |
Assiut University | N/A |
Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Phase 2 |
Pharmacology for NORTRIPTYLINE HYDROCHLORIDE
Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for NORTRIPTYLINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for NORTRIPTYLINE HYDROCHLORIDE
US Patents and Regulatory Information for NORTRIPTYLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Sa | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 073556-002 | Mar 30, 1992 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 073667-004 | Apr 11, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 074132-003 | Mar 27, 1995 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 073667-003 | Apr 11, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORTRIPTYLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | AVENTYL HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 014684-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | CAPSULE;ORAL | 018013-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Specgx Llc | PAMELOR | nortriptyline hydrochloride | SOLUTION;ORAL | 018012-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ranbaxy | AVENTYL | nortriptyline hydrochloride | SOLUTION;ORAL | 014685-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.